Dosage and administration
TAKE 2 PUMP SPRAYS 3 TIMES A DAILY. HOLD UNDER TONGUE FOR 30 SECONDS BEFORE SWALLOWING. MORE FREQUENT DOSAGES MAY BE USED ACCORDING TO SYMPTOMATIC NEEDS. FOR AGES 12 TO ADULT
TAKE 2 PUMP SPRAYS 3 TIMES A DAILY. HOLD UNDER TONGUE FOR 30 SECONDS BEFORE SWALLOWING. MORE FREQUENT DOSAGES MAY BE USED ACCORDING TO SYMPTOMATIC NEEDS. FOR AGES 12 TO ADULT
EACH MULTI POTENCIES OF 12X, 30X, LM1
ADRENALINUM
CHOLESTERINUM
FOLLICULINUM
HYPOTHALAMUS
OOPHORINUM
PULSATILLA
TAKE 2 PUMP SPRAYS 3 TIMES A DAILY. HOLD UNDER TONGUE FOR 30 SECONDS BEFORE SWALLOWING. MORE FREQUENT DOSAGES MAY BE USED ACCORDING TO SYMPTOMATIC NEEDS. FOR AGES 12 TO ADULT
KEEP OUT OF REACH OF CHILDREN
WARNING: WARNINGS: STOP USE AND CALL A DOCTOR if symptoms persist or worsen. CONTAINS ALCOHOL: in case of accidental overdose, consult a poison control center immediately
OTHER INFORMATION: Tamper resistant for your protection. Use only if safety seal is intact
IF PREGNANT OR BREAST FEEDING, consult a healthcare professional before use
FOR HORMONAL IMBALANCES ASSOCIATED WITH PREMENSTRUAL SYNDROME, IRREGULAR MENSTRUAL CYCLE, WATER RETENTION, DEPRESSION, IRRITABILITY AND MOODINESS
POTASSIUM SORBATE, CITRIC ACID, PURIFIED WATER
INDICATIONS: FORTHE TEMPORARY RELIEF OF HORMONAL IMBALANCES ASSOCIATED WITH PREMENSTRUAL SYNDROME, IRREGULAR MENSTRUAL CYCLE, WATER RETENTION, DEPRESSION, IRRITABILITY AND MOODINESS
MANUFACTURED FOR
MICRO-WEST
P.O. Box 950
DOUGLAS, WY 82633
1-307-358-5066
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 61657-0971-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-effc-f424-e053-dadaa90a57ce | DRUG FACTS |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61657-0971-1 | TOTAL FEM-BAL | 30 mL in 1 BOTTLE, PUMP | LIQUID | 30 | 4 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 61657-0971 | TOTAL FEM-BAL (ADRENALINUM,PULSATILLA,CHOLESTERINUM,FOLLICULINUM,HYPOTHALAMUS,OOPHORINUM,ADRENAL CORTEX, ANDROSTENEDIONE,DHEA,PREGNANOLONE,PROGESTERONE,TESTERONE) LIQUID [WHITE MANUFACTURING INC. DBA MICRO WEST] | 4 | Legacy NDC, 1 package rows | 20140819_04daddb5-009c-46e8-96be-334e489a6d6c.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ANDROSTENEDIONE | ACTIVE INGREDIENT | 409J2J96VR | 4 | |
| BOS TAURUS HYPOTHALAMUS | ACTIVE INGREDIENT | S6G2NLH4Y7 | 4 | |
| CHOLESTEROL | ACTIVE INGREDIENT | 97C5T2UQ7J | 4 | |
| EPINEPHRINE | ACTIVE INGREDIENT | YKH834O4BH | 4 | |
| ESTRONE | ACTIVE INGREDIENT | 2DI9HA706A | 4 | |
| PRASTERONE | ACTIVE INGREDIENT | 459AG36T1B | 4 | |
| PREGNENOLONE | ACTIVE INGREDIENT | 73R90F7MQ8 | 4 | |
| PROGESTERONE | ACTIVE INGREDIENT | 4G7DS2Q64Y | 4 | |
| PULSATILLA VULGARIS | ACTIVE INGREDIENT | I76KB35JEV | 4 | |
| SUS SCROFA ADRENAL GLAND | ACTIVE INGREDIENT | 398IYQ16YV | 4 | |
| SUS SCROFA OVARY | ACTIVE INGREDIENT | S7YTV04R8O | 4 | |
| TESTOSTERONE | ACTIVE INGREDIENT | 3XMK78S47O | 4 | |
| ANDROSTENEDIONE | ACTIVE MOIETY | 409J2J96VR | 4 | |
| BOS TAURUS HYPOTHALAMUS | ACTIVE MOIETY | S6G2NLH4Y7 | 4 | |
| CHOLESTEROL | ACTIVE MOIETY | 97C5T2UQ7J | 4 | |
| EPINEPHRINE | ACTIVE MOIETY | YKH834O4BH | 4 | |
| ESTRONE | ACTIVE MOIETY | 2DI9HA706A | 4 | |
| PRASTERONE | ACTIVE MOIETY | 459AG36T1B | 4 | |
| PREGNENOLONE | ACTIVE MOIETY | 73R90F7MQ8 | 4 | |
| PROGESTERONE | ACTIVE MOIETY | 4G7DS2Q64Y | 4 | |
| PULSATILLA VULGARIS | ACTIVE MOIETY | I76KB35JEV | 4 | |
| SUS SCROFA ADRENAL GLAND | ACTIVE MOIETY | 398IYQ16YV | 4 | |
| SUS SCROFA OVARY | ACTIVE MOIETY | S7YTV04R8O | 4 | |
| TESTOSTERONE | ACTIVE MOIETY | 3XMK78S47O | 4 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 4 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 61657-0971 | 61657-0971-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| EPINEPHRINE | YKH834O4BH | ACTIB |
| PULSATILLA VULGARIS | I76KB35JEV | ACTIB |
| CHOLESTEROL | 97C5T2UQ7J | ACTIB |
| ESTRONE | 2DI9HA706A | ACTIB |
| BOS TAURUS HYPOTHALAMUS | S6G2NLH4Y7 | ACTIB |
| SUS SCROFA OVARY | S7YTV04R8O | ACTIB |
| ANDROSTENEDIONE | 409J2J96VR | ACTIB |
| PRASTERONE | 459AG36T1B | ACTIB |
| PREGNENOLONE | 73R90F7MQ8 | ACTIB |
| PROGESTERONE | 4G7DS2Q64Y | ACTIB |
| TESTOSTERONE | 3XMK78S47O | ACTIB |
| SUS SCROFA ADRENAL GLAND | 398IYQ16YV | ACTIB |
| POTASSIUM SORBATE | 1VPU26JZZ4 | IACT |
| CITRIC ACID MONOHYDRATE | 2968PHW8QP | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SHAMPOO / TOPICAL | 17 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAPLEURAL | ADJ PH | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SYRUP / ORAL | 2 mg/1ml | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CAPSULE / ORAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | DROPS / ORAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRAVENOUS | 396 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | EMULSION / TOPICAL | 0.11 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / IONTOPHORESIS | 0.02 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CREAM / TOPICAL | 0.25 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | GEL / TOPICAL | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | FILM, EXTENDED RELEASE / TRANSDERMAL | 1.38 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / EPIDURAL | 0.02 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | POWDER, FOR SUSPENSION / ORAL | 19 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRALESIONAL | ADJ PH | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION/ DROPS / OPHTHALMIC | 0.47 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, EFFERVESCENT / ORAL | 460 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, ORALLY DISINTEGRATING / ORAL | 83 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | PASTE / ORAL | 48 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | EMULSION / OPHTHALMIC | 0.47 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INFILTRATION | 0.02 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / AURICULAR (OTIC) | 0.04 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / RESPIRATORY (INHALATION) | 0.03 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYRUP / ORAL | 722 mg/5ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / SUBCUTANEOUS | 28 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAMUSCULAR | 0.05 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TROCHE / ORAL | 12 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION, EXTENDED RELEASE / ORAL | 140.8 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | ELIXIR / ORAL | 100 mg/5ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRABURSAL | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, CHEWABLE / ORAL | 7 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION / ORAL | 1000 mg/15ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAMUSCULAR | 28 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER / ORAL | 840 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / TOPICAL | 17 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | OINTMENT / TOPICAL | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRA-ARTICULAR | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRAMUSCULAR | 26 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CONCENTRATE / ORAL | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRASYNOVIAL | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAOCULAR | 1 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, COATED / ORAL | NA | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | AEROSOL, FOAM / TOPICAL | 8 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / INTRAVENOUS | 0.2 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION/ DROPS / ORAL | 19 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LOTION / TOPICAL | 0.85 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / ORAL | 114 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / AURICULAR (OTIC) | 0.2 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY / NASAL | 9 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / BUCCAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET / SUBLINGUAL | 24 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | LOTION / TOPICAL | 0.2 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 385 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | AEROSOL, FOAM / TOPICAL | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | DOUCHE / VAGINAL | 0.07 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 38 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / SOFT TISSUE | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SUSPENSION / ORAL | 840 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 41aa131b-f353-4a65-9b7e-451e7beafc9b | 04daddb5-009c-46e8-96be-334e489a6d6c | 2014-08-18 | Warnings | 41aa131b-f353-4a65-9b7e-451e7beafc9b 04daddb5-009c-46e8-96be-334e489a6d6c |
Adverse event summaries are temporarily unavailable. Other product information remains available.